These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6271784)

  • 21. Structure and activation of C1: current concepts.
    Colomb MG; Arlaud GJ; Villiers CL
    Complement; 1984; 1(2):69-80. PubMed ID: 6100485
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.
    Reboul A; Bensa JC; Colomb MG
    Biochem J; 1986 Jan; 233(2):559-64. PubMed ID: 3006672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assignment of the complement serine protease genes C1r and C1s to chromosome 12 region 12p13.
    Nguyen VC; Tosi M; Gross MS; Cohen-Haguenauer O; Jegou-Foubert C; de Tand MF; Meo T; Frézal J
    Hum Genet; 1988 Apr; 78(4):363-8. PubMed ID: 2834284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1.
    Thielens NM; Villiers MB; Reboul A; Villiers CL; Colomb MG
    FEBS Lett; 1982 May; 141(1):19-24. PubMed ID: 6282646
    [No Abstract]   [Full Text] [Related]  

  • 25. The cleavage of two C1s subunits by a single active C1r reveals substantial flexibility of the C1s-C1r-C1r-C1s tetramer in the C1 complex.
    Lörincz Z; Gál P; Dobó J; Cseh S; Szilágyi K; Ambrus G; Závodszky P
    J Immunol; 2000 Aug; 165(4):2048-51. PubMed ID: 10925288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complement component C1s catalysed hydrolysis of peptide 4-nitroanilide substrates.
    Keogh SJ; Harding DR; Hardman MJ
    Biochim Biophys Acta; 1987 May; 913(1):39-44. PubMed ID: 3495295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluid phase activation of proenzymic C1r purified by affinity chromatography.
    Villiers CL; Duplaa AM; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1982 Jan; 700(1):118-26. PubMed ID: 6275893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
    Ghebrehiwet B; Randazzo BP; Dunn JT; Silverberg M; Kaplan AP
    J Clin Invest; 1983 May; 71(5):1450-6. PubMed ID: 6304147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
    Hsiung L; Dodds AW; Mason DW; Reid KB
    FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human genes for complement components C1r and C1s in a close tail-to-tail arrangement.
    Kusumoto H; Hirosawa S; Salier JP; Hagen FS; Kurachi K
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7307-11. PubMed ID: 2459702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium-sensitive thermal transitions and domain structure of human complement subcomponent C1r.
    Busby TF; Ingham KC
    Biochemistry; 1987 Aug; 26(17):5564-71. PubMed ID: 2823884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and properties of human C1 inhibitor.
    Sim RB; Reboul A
    Methods Enzymol; 1981; 80 Pt C():43-54. PubMed ID: 6281621
    [No Abstract]   [Full Text] [Related]  

  • 33. Purification of subcomponents Clq, Cl(-)r and Cl(-)s of the first component of complement from Cohn Fraction I by affinity chromatography.
    Bing DH; Andrews JM; Morris KM; Cole E; Irish V
    Prep Biochem; 1980; 10(3):269-96. PubMed ID: 6251443
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular characterization of the catalytic domains of human complement serine protease C1r.
    Arlaud GJ; Gagnon J; Villiers CL; Colomb MG
    Biochemistry; 1986 Sep; 25(18):5177-82. PubMed ID: 3021210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of human complement subcomponents C1r and C1s in their unactivated, proenzyme forms.
    Lane PD; Schumaker VN; Tseng Y; Poon PH
    J Immunol Methods; 1991 Aug; 141(2):219-26. PubMed ID: 1880428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NH2-terminal calcium-binding domain of human complement C1s- mediates the interaction of C1r- with C1q.
    Busby TF; Ingham KC
    Biochemistry; 1990 May; 29(19):4613-8. PubMed ID: 2372546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of C1 and concentration dependence of its activation kinetics.
    Kilchherr E; Fuchs H; Tschopp J; Engel J
    Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.
    Lacroix MB; Aude CA; Arlaud GJ; Colomb MG
    Biochem J; 1989 Feb; 257(3):885-91. PubMed ID: 2539098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and activity of C1r and C1s.
    Carter PE; Dunbar B; Fothergill JE
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):293-9. PubMed ID: 6149574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.